Loading...

Genfit S.A.

GNFTYPNK
Healthcare
Biotechnology
$8.95
$0.00(0.00%)
U.S. Market opens in 0h 53m

Genfit S.A. Fundamental Analysis

Genfit S.A. (GNFTY) shows weak financial fundamentals with a PE ratio of -10.60, profit margin of -92.90%, and ROE of -69.11%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position24.13%
PEG Ratio-0.11
Current Ratio3.74

Areas of Concern

ROE-69.11%
Operating Margin-75.08%
We analyze GNFTY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -137.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-137.9/100

We analyze GNFTY's fundamental strength across five key dimensions:

Efficiency Score

Weak

GNFTY struggles to generate sufficient returns from assets.

ROA > 10%
-19.41%

Valuation Score

Excellent

GNFTY trades at attractive valuation levels.

PE < 25
-10.60
PEG Ratio < 2
-0.11

Growth Score

Weak

GNFTY faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

GNFTY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.14
Current Ratio > 1
3.74

Profitability Score

Weak

GNFTY struggles to sustain strong margins.

ROE > 15%
-6911.37%
Net Margin ≥ 15%
-92.90%
Positive Free Cash Flow
No

Key Financial Metrics

Is GNFTY Expensive or Cheap?

P/E Ratio

GNFTY trades at -10.60 times earnings. This suggests potential undervaluation.

-10.60

PEG Ratio

When adjusting for growth, GNFTY's PEG of -0.11 indicates potential undervaluation.

-0.11

Price to Book

The market values Genfit S.A. at 8.49 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

8.49

EV/EBITDA

Enterprise value stands at -15.55 times EBITDA. This is generally considered low.

-15.55

How Well Does GNFTY Make Money?

Net Profit Margin

For every $100 in sales, Genfit S.A. keeps $-92.90 as profit after all expenses.

-92.90%

Operating Margin

Core operations generate -75.08 in profit for every $100 in revenue, before interest and taxes.

-75.08%

ROE

Management delivers $-69.11 in profit for every $100 of shareholder equity.

-69.11%

ROA

Genfit S.A. generates $-19.41 in profit for every $100 in assets, demonstrating efficient asset deployment.

-19.41%

Following the Money - Real Cash Generation

Operating Cash Flow

Genfit S.A. generates limited operating cash flow of $-4.03M, signaling weaker underlying cash strength.

$-4.03M

Free Cash Flow

Genfit S.A. generates weak or negative free cash flow of $-5.45M, restricting financial flexibility.

$-5.45M

FCF Per Share

Each share generates $-0.11 in free cash annually.

$-0.11

FCF Yield

GNFTY converts -1.21% of its market value into free cash.

-1.21%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-10.60

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.11

vs 25 benchmark

P/B Ratio

Price to book value ratio

8.49

vs 25 benchmark

P/S Ratio

Price to sales ratio

9.89

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.14

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.74

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.69

vs 25 benchmark

ROA

Return on assets percentage

-0.19

vs 25 benchmark

ROCE

Return on capital employed

-0.19

vs 25 benchmark

How GNFTY Stacks Against Its Sector Peers

MetricGNFTY ValueSector AveragePerformance
P/E Ratio-10.6029.06 Better (Cheaper)
ROE-69.11%646.00% Weak
Net Margin-92.90%-44088.00% (disorted) Weak
Debt/Equity0.140.33 Strong (Low Leverage)
Current Ratio3.744.49 Strong Liquidity
ROA-19.41%-15444.00% (disorted) Weak

GNFTY outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Genfit S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ